NCT02296229View on ClinicalTrials.gov

Stereotactic Body Radiation Therapy in Treating Patients With Localized High-Risk Prostate Cancer

NAActive, not recruitingINTERVENTIONAL
Enrollment

220

Participants

Timeline

Start Date

January 27, 2014

Primary Completion Date

January 27, 2026

Study Completion Date

January 27, 2027

Conditions
Adenocarcinoma of the ProstateStage III Prostate Cancer
Interventions
RADIATION

stereotactic body radiation therapy

Undergo SBRT

OTHER

quality-of-life assessment

Ancillary studies

OTHER

laboratory biomarker analysis

Correlative studies

DRUG

androgen deprivation therapy

up to 9 months at the discretion of the treating physician

Trial Locations (1)

90095

Jonsson Comprehensive Cancer Center, Los Angeles

All Listed Sponsors
lead

Jonsson Comprehensive Cancer Center

OTHER